SVENSKA CELLULO (Germany) Performance
| SCA Stock | EUR 15.62 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and SVENSKA CELLULO are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days SVENSKA CELLULO B has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, SVENSKA CELLULO is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 1.3 B | |
| Free Cash Flow | 863 M |
SVENSKA |
SVENSKA CELLULO Relative Risk vs. Return Landscape
If you would invest 1,562 in SVENSKA CELLULO B on October 6, 2024 and sell it today you would earn a total of 0.00 from holding SVENSKA CELLULO B or generate 0.0% return on investment over 90 days. SVENSKA CELLULO B is producing return of less than zero assuming 0.0% volatility of returns over the 90 days investment horizon. Simply put, 0% of all stocks have less volatile historical return distribution than SVENSKA CELLULO, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
SVENSKA CELLULO Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SVENSKA CELLULO's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SVENSKA CELLULO B , and traders can use it to determine the average amount a SVENSKA CELLULO's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SCA |
Based on monthly moving average SVENSKA CELLULO is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SVENSKA CELLULO by adding SVENSKA CELLULO to a well-diversified portfolio.
SVENSKA CELLULO Fundamentals Growth
SVENSKA Stock prices reflect investors' perceptions of the future prospects and financial health of SVENSKA CELLULO, and SVENSKA CELLULO fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SVENSKA Stock performance.
| Current Valuation | 8.91 B | |||
| Price To Book | 1.51 X | |||
| Price To Sales | 6.22 X | |||
| Revenue | 18.82 B | |||
| EBITDA | 9.11 B | |||
| Total Debt | 8.58 B | |||
| Cash Flow From Operations | 5.97 B | |||
| Total Asset | 118.23 B | |||
About SVENSKA CELLULO Performance
By analyzing SVENSKA CELLULO's fundamental ratios, stakeholders can gain valuable insights into SVENSKA CELLULO's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SVENSKA CELLULO has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SVENSKA CELLULO has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about SVENSKA CELLULO B performance evaluation
Checking the ongoing alerts about SVENSKA CELLULO for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SVENSKA CELLULO B help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SVENSKA CELLULO B is not yet fully synchronised with the market data | |
| SVENSKA CELLULO B generated a negative expected return over the last 90 days |
- Analyzing SVENSKA CELLULO's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SVENSKA CELLULO's stock is overvalued or undervalued compared to its peers.
- Examining SVENSKA CELLULO's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SVENSKA CELLULO's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SVENSKA CELLULO's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SVENSKA CELLULO's stock. These opinions can provide insight into SVENSKA CELLULO's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for SVENSKA Stock analysis
When running SVENSKA CELLULO's price analysis, check to measure SVENSKA CELLULO's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SVENSKA CELLULO is operating at the current time. Most of SVENSKA CELLULO's value examination focuses on studying past and present price action to predict the probability of SVENSKA CELLULO's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SVENSKA CELLULO's price. Additionally, you may evaluate how the addition of SVENSKA CELLULO to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |